Inhibrx, Inc. (INBX)
NASDAQ: INBX · IEX Real-Time Price · USD
13.73
+0.30 (2.23%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Inhibrx Market Cap
Inhibrx has a market cap or net worth of $198.75 million as of July 26, 2024.
Market Cap
198.75M
Enterprise Value
195.93M
1-Year Change
n/a
Ranking
Category
Stock Price
$13.73
Market Cap Chart
Since the IPO on August 19, 2020, Inhibrx's market cap has decreased from $606.13M to $198.75M, a decrease of -67.21%. That is a compound annual growth rate of -24.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 179.70M | -70.35% |
| Aug 19, 2020 | 606.13M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 908 Devices | 194.84M |
| Alpha Teknova | 192.85M |
| OptimizeRx | 192.56M |
| Candel Therapeutics | 192.07M |
| Outlook Therapeutics | 191.69M |
| Accuray | 191.54M |
| Renovaro Biosciences | 188.81M |
| Rigel Pharmaceuticals | 188.05M |